Cureveda
2010
FOUNDED
OOB
STATUS
1-10
EMPLOYEES
Out of Business
LATEST DEAL TYPE
Description
Operator of a biotechnology company intended to develops therapies for the treatment of chronic diseases. The company's biotechnology services include developing small molecules targeting Nrf2 pathway for treatment of chronic obstructive pulmonary disease and other inflammatory disorders, enabling patients to counteract inflammation and cellular dysfunction caused due to oxidative stress.
Website
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
- 1450 South Rolling Road
- Halethorpe, MD 21227
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Cureveda’s full profile, request a free trial.
Cureveda Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Sep-2016 | 00000 | Completed | Out of Business | ||
| 2. Grant | 07-Sep-2014 | 00000 | 00000 | Completed | Startup | |
| 1. Accelerator/Incubator | $100K | $100K | Completed | Startup |
Cureveda Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Graham Allaway Ph.D | Chief Executive Officer | ||
| Rajesh Thimmulappa Ph.D | Co-Founder |
2 Former Executives
You’re viewing 2 of 4 executives. Get the full list »